Moreover, EC@HNA reprogrammed the immune microenvironment by lowering IL-10 and TGF-β levels, thereby decreasing Treg cell accumulation, increasing CD8+ T cell infiltration, and ultimately retarding the progression of ENZR PCa (Figure 1H). The gene discussed is CD8A; the disease is posterior cortical atrophy.